The Discounted Cash Flow (DCF) valuation of Zealand Pharma A/S (ZEAL.CO) is 1,274.48 DKK. With the latest stock price at 298.00 DKK, the upside of Zealand Pharma A/S based on DCF is 327.7%.
Based on the latest price of 298.00 DKK and our DCF valuation, Zealand Pharma A/S (ZEAL.CO) is a buy. buying ZEAL.CO stocks now will result in a potential gain of 327.7%.
| Range | Selected | |
| WACC / Discount Rate | 7.9% - 10.2% | 9.1% |
| Long-term Growth Rate | 0.0% - 1.0% | 0.5% |
| Fair Price | 1,096.48 - 1,535.62 | 1,274.48 |
| Upside | 267.9% - 415.3% | 327.7% |